Clinical trial

Study of Tissue Samples From Patients With Stage I Non-Small Cell Lung Cancer Enrolled on Research Study CALGB-140202

NCT00990873

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

GENETIC · Unmapped registry intervention gene expression analysis Find medicine records · Find other trials using this name

GENETIC · Unmapped registry intervention microarray analysis Find medicine records · Find other trials using this name

GENETIC · Unmapped registry intervention reverse transcriptase-polymerase chain reaction Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention laboratory biomarker analysis Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Study of Tissue Samples From Patients With Stage I Non-Small Cell Lung Cancer Enrolled on Research Study CALGB-140202

Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2009-07-01

PhaseN/A

Conditions

Lung Cancerverified · MONDO: lung cancer

Interventions

gene expression analysisGENETIC

microarray analysisGENETIC

reverse transcriptase-polymerase chain reactionGENETIC

laboratory biomarker analysisOTHER

Sponsors & collaborators

Alliance for Clinical Trials in Oncologylead sponsor

National Cancer Institute (NCI)collaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00990873 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.